Translational research in gliomas: Quo Vadis?
So, whatever one's definition of TR is, TR is clearly changing the landscape in the world of glioma neuro-oncology. We are in a rich era of progress relating clinical observations and management with laboratory discoveries and vice versa. Foremost among these symbiotic relationships are developments in imaging, molecular diagnostics, preclinical testing of therapeutics, clinical trials (medical and surgical), stem cells, and tumor banking. Although described by some as the "molecular era" of human brain tumor management, it is probably more accurate to describe it as the era of "translational research."
Barnett
Gene H
GH
Department of Neurosurgery, Brain Tumor Institute, The Cleveland Clinic Tausig Cancer Center, Ohio, USA.
D035843:Biomedical Research / Q000458:organization & administration*; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D005910:Glioma / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans